MHRA
Keeping tabs on Covid-19: UK approves safety of Pfizer and BioNTech’s Covid-19 vaccine
December 04 by Emily UwemedimoA breakthrough and scientific achievement for Pfizer and BioNTech as they receive the green light from UK regulators to help in the fight to end the pandemic
MHRA grants UK patients early access to treatment for painful genetic disorder
March 26 by Chanice HenryA treatment for a debilitating genetic lipid disorder has been awarded a place on the Early Access to Medicines Scheme by the MHRA.
MHRA Inspectors & Industry Members Meet at MHRA GPvP Symposium
November 24 by Chanice HenryEarlier this month the MHRA held its annual Good Pharmacovigilance Practice (GPvP) Symposium, which saw MHRA pharmacovigilance inspectors and industry members gather to interact and discuss how to dev...
Fire Your Medical Device Questions For The MHRA This Way
September 30 by Pharma IQ Surveys[surveycode]
The MHRA Review and Clinical Trials in Cancer
January 17 by Helen WinsorJames McBlane, Preclinical Assessor in the Clinical Trials Unit, Medicines & Healthcare products Regulatory Agency (MHRA), joins Pharma IQ to discuss clinical trials in patients with advanced...
Industry To Meet As MHRA, Dutch Healthcare Inspectorate and PDA Join 30 Industry Leaders Sharing their Views on Innovation in Clinical Trial Supply Practice and Regulations
January 05 by Pharma IQ NewsIn the wake of a transformed pharmaceutical market due to mergers and acquisitions, industry leaders are to converge in Rotterdam on 27th-28th January 2011, to discuss the latest push in cost cutting...
A Year in European Variations Regulation
December 20 by Pharma IQVariations, regardless of their simplicity, are still required to pass through a complex regulatory process for the products to remain authorised for sale on the market. The process is essential...
Industry to Meet as MHRA, the Dutch Healthcare Inspectorate and the PDA Join 30 Industry Leaders Sharing their Views on Innovation in Clinical Trial Supply Practice and Regulations
November 03 by Pharma IQ NewsIn the wake of a transformed pharmaceutical market due to mergers and acquisitions, industry leaders are to converge in Rotterdam on 27th-28th January 2011, to discuss the latest push in cost cuttin...
Leading Regulatory Bodies, Pharmaceutical and Biotech Companies Including MHRA, FAGGS and BfArM to Address the Challenges Facing Today's Phase I Trials
July 06 by Pharma IQ NewsLONDON- Pharma IQ is pleased to announce the dates for the Innovation in Phase I Clinical Development conference taking place on 21st and 22nd September 2010. With the focus on cost control more...
When Does an App Become a Medical Device? An Interview with Rob Higgins, Regulatory Affairs Manager, MHRA
April 18 by Rob HigginsIn this exclusive Pharma IQ interview Rob Higgins, Regulatory Affairs Manager for the Medicines and Healthcare Products Regulatory Agency (MHRA), discusses the implications of medical device regulat...
MHRA's Ian Holloway on Revision Annex 16 of the GMP Guide and the Cold Chain
April 18 by Pharmaceuticals & Biotechnology EditorIan Holloway, Manager of the Defective Medicines Report Centre at the Medicines and Healthcare products Regulatory Agency (MHRA), joins Andrea Charles from Cold Chain IQ, to discuss how the role of...
MHRA Update on the Requirements of Licensed Facilities for Handling 2-8°C Products
April 18 by Pharmaceuticals & Biotechnology EditorIn this presentation Ian Holloway, Senior Pharmaceutical Assessor for the MHRA, discusses: Updates on new license requirements for 2-8°C handling Expectations for handling and storage...